Menu
Back to User profile » Dr Jiafu Ji
Papers published by Dr Jiafu Ji:
5-Fu-Based Doublet Regimen in Patients Receiving Perioperative or Postoperative Chemotherapy for Locally Advanced Gastric Cancer: When to Start and How Long Should the Regimen Last?
Liu Z, Wang Y, Shan F, Ying X, Zhang Y, Li S, Jia Y, Li Z, Ji J
Cancer Management and Research 2021, 13:147-161
Published Date: 11 January 2021
A Modified ypTNM Staging System–Development and External Validation of a Nomogram Predicting the Overall Survival of Gastric Cancer Patients Received Neoadjuvant Chemotherapy
Li Z, Xiao Q, Wang Y, Wang W, Li S, Shan F, Zhou Z, Ji J
Cancer Management and Research 2020, 12:2047-2055
Published Date: 19 March 2020
EIF3B is associated with poor outcomes in gastric cancer patients and promotes cancer progression via the PI3K/AKT/mTOR signaling pathway
Wang L, Wen X, Luan F, Fu T, Gao C, Du H, Guo T, Han J, Huangfu L, Cheng X, Ji J
Cancer Management and Research 2019, 11:7877-7891
Published Date: 21 August 2019
The novel lncRNA p4516 acts as a prognostic biomarker promoting gastric cancer cell proliferation and metastasis
Nie ML, Han J, Huang HC, Guo T, Huangfu LT, Cheng XJ, Li XM, Du H, Li QD, Wen XZ, Ji JF
Cancer Management and Research 2019, 11:5375-5391
Published Date: 12 June 2019
Higher autocrine motility factor/glucose-6-phosphate isomerase expression is associated with tumorigenesis and poorer prognosis in gastric cancer
Ma YT, Xing XF, Dong B, Cheng XJ, Guo T, Du H, Wen XZ, Ji JF
Cancer Management and Research 2018, 10:4969-4980
Published Date: 25 October 2018